Cargando…

Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo

Kisspeptins regulate the mammalian reproductive axis by stimulating release of gonadotrophin releasing hormone (GnRH). Different length kisspeptins (KP) are found of 54, 14, 13 or 10 amino-acids which share a common C-terminal 10-amino acid sequence. KP-54 and KP-10 have been widely used to stimulat...

Descripción completa

Detalles Bibliográficos
Autores principales: d'Anglemont de Tassigny, Xavier, Jayasena, Channa, Murphy, Kevin G., Dhillo, Waljit S., Colledge, William H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413024/
https://www.ncbi.nlm.nih.gov/pubmed/28464043
http://dx.doi.org/10.1371/journal.pone.0176821
_version_ 1783233120677396480
author d'Anglemont de Tassigny, Xavier
Jayasena, Channa
Murphy, Kevin G.
Dhillo, Waljit S.
Colledge, William H.
author_facet d'Anglemont de Tassigny, Xavier
Jayasena, Channa
Murphy, Kevin G.
Dhillo, Waljit S.
Colledge, William H.
author_sort d'Anglemont de Tassigny, Xavier
collection PubMed
description Kisspeptins regulate the mammalian reproductive axis by stimulating release of gonadotrophin releasing hormone (GnRH). Different length kisspeptins (KP) are found of 54, 14, 13 or 10 amino-acids which share a common C-terminal 10-amino acid sequence. KP-54 and KP-10 have been widely used to stimulate the reproductive axis but data suggest that KP-54 and KP-10 are not equally effective at eliciting reproductive hormone secretion after peripheral delivery. To confirm this, we analysed the effect of systemic administration of KP-54 or KP-10 on luteinizing hormone (LH) secretion into the bloodstream of male mice. Plasma LH measurements 10 min or 2 hours after kisspeptin injection showed that KP-54 can sustain LH release far longer than KP-10, suggesting a differential mode of action of the two peptides. To investigate the mechanism for this, we evaluated the pharmacokinetics of the two peptides in vivo and their potential to cross the blood brain barrier (BBB). We found that KP-54 has a half-life of ~32 min in the bloodstream, while KP-10 has a half-life of ~4 min. To compensate for this difference in half-life, we repeated injections of KP-10 every 10 min over 1 hr but failed to reproduce the sustained rise in LH observed after a single KP-54 injection, suggesting that the failure of KP-10 to sustain LH release may not just be related to peptide clearance. We tested the ability of peripherally administered KP-54 and KP-10 to activate c-FOS in GnRH neurons behind the blood brain barrier (BBB) and found that only KP-54 could do this. These data are consistent with KP-54 being able to cross the BBB and suggest that KP10 may be less able to do so.
format Online
Article
Text
id pubmed-5413024
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54130242017-05-14 Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo d'Anglemont de Tassigny, Xavier Jayasena, Channa Murphy, Kevin G. Dhillo, Waljit S. Colledge, William H. PLoS One Research Article Kisspeptins regulate the mammalian reproductive axis by stimulating release of gonadotrophin releasing hormone (GnRH). Different length kisspeptins (KP) are found of 54, 14, 13 or 10 amino-acids which share a common C-terminal 10-amino acid sequence. KP-54 and KP-10 have been widely used to stimulate the reproductive axis but data suggest that KP-54 and KP-10 are not equally effective at eliciting reproductive hormone secretion after peripheral delivery. To confirm this, we analysed the effect of systemic administration of KP-54 or KP-10 on luteinizing hormone (LH) secretion into the bloodstream of male mice. Plasma LH measurements 10 min or 2 hours after kisspeptin injection showed that KP-54 can sustain LH release far longer than KP-10, suggesting a differential mode of action of the two peptides. To investigate the mechanism for this, we evaluated the pharmacokinetics of the two peptides in vivo and their potential to cross the blood brain barrier (BBB). We found that KP-54 has a half-life of ~32 min in the bloodstream, while KP-10 has a half-life of ~4 min. To compensate for this difference in half-life, we repeated injections of KP-10 every 10 min over 1 hr but failed to reproduce the sustained rise in LH observed after a single KP-54 injection, suggesting that the failure of KP-10 to sustain LH release may not just be related to peptide clearance. We tested the ability of peripherally administered KP-54 and KP-10 to activate c-FOS in GnRH neurons behind the blood brain barrier (BBB) and found that only KP-54 could do this. These data are consistent with KP-54 being able to cross the BBB and suggest that KP10 may be less able to do so. Public Library of Science 2017-05-02 /pmc/articles/PMC5413024/ /pubmed/28464043 http://dx.doi.org/10.1371/journal.pone.0176821 Text en © 2017 d'Anglemont de Tassigny et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
d'Anglemont de Tassigny, Xavier
Jayasena, Channa
Murphy, Kevin G.
Dhillo, Waljit S.
Colledge, William H.
Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
title Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
title_full Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
title_fullStr Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
title_full_unstemmed Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
title_short Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
title_sort mechanistic insights into the more potent effect of kp-54 compared to kp-10 in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413024/
https://www.ncbi.nlm.nih.gov/pubmed/28464043
http://dx.doi.org/10.1371/journal.pone.0176821
work_keys_str_mv AT danglemontdetassignyxavier mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo
AT jayasenachanna mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo
AT murphykeving mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo
AT dhillowaljits mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo
AT colledgewilliamh mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo